Prevymis (letermovir) - Merck (MSD)
247 - It's a Small World After All: Prevention and Treatment in the Expanding World of Pediatric Immunocompromised Hosts (IDWeek 2025) - Jul 27, 2025 - Pres time: Oct 22, 2025; 01:45 PM - 03:00 PM; Location: B302-B304; "Learning Objectives: At the conclusion of this session, participants will be able to: discuss current approaches to infection prophylaxis in neutropenic hosts and their limitations and solutions; describe how antimicrobial use can be optimized in pediatric patients with fever and neutropenia; describe the evidence-based use of letermovir in pediatric transplant recipients." 
Clinical • Infectious Disease
https://idweek2025.eventscribe.net/fsPopup.asp?PresentationID=1607936&mode=sessionInfo
 
Kengo Inagaki, MD; Natalie Dailey Garnes, MD, MPH, MS (she/her/hers)
 
Jul 27, 2025
 
Prev Next